MiMedx Group (MDXG) Issues Letter to Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
MIMEDX Mails Letter to Shareholders
May 16, 2022 8:00 AM EDTHighlights Successful Execution of Transformation Strategy Under CEO Tim Wright
Reaffirms Commitment to Enhancing Value for ALL Shareholders
Urges Shareholders to Vote FOR Both of MIMEDXs Highly Qualified Director Nominees James L. Bierman and Phyllis Gardner, M.D. on the WHITE Proxy Card
MARIETTA, Ga., May 16, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ: MDXG) (MIMEDX or the Company), a transformational placental biologics company, has mailed a letter to shareholders in connection with its 2022 Annual Meeting of Shareholders scheduled for... More
